Cyclerion Therapeutics (NASDAQ:CYCN) Trading Up 9.9% on Insider Buying Activity

Share on StockTwits

Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s stock price was up 9.9% during trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as $2.13 and last traded at $2.00, approximately 1,661,600 shares changed hands during mid-day trading. An increase of 482% from the average daily volume of 285,576 shares. The stock had previously closed at $1.82.

Specifically, insider Andreas Busch bought 125,000 shares of the stock in a transaction dated Friday, November 15th. The shares were acquired at an average cost of $1.82 per share, for a total transaction of $227,500.00. Following the completion of the transaction, the insider now owns 125,000 shares in the company, valued at approximately $227,500. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

The firm’s 50-day moving average is $6.61 and its 200 day moving average is $10.42. The company has a debt-to-equity ratio of 0.60, a current ratio of 6.32 and a quick ratio of 6.32.

Large investors have recently modified their holdings of the stock. Russell Investments Group Ltd. purchased a new position in Cyclerion Therapeutics during the 3rd quarter worth $1,112,000. First Trust Advisors LP purchased a new stake in shares of Cyclerion Therapeutics in the third quarter valued at about $430,000. California Public Employees Retirement System acquired a new stake in shares of Cyclerion Therapeutics during the third quarter worth about $404,000. Finally, Broderick Brian C acquired a new stake in shares of Cyclerion Therapeutics during the third quarter worth about $399,000. Hedge funds and other institutional investors own 72.16% of the company’s stock.

About Cyclerion Therapeutics (NASDAQ:CYCN)

There is no company description available for Cyclerion Therapeutics Inc

Further Reading: Are FAANG stocks a good investment?

Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Del Taco Restaurants Inc  Receives $11.00 Consensus PT from Analysts
Del Taco Restaurants Inc Receives $11.00 Consensus PT from Analysts
Analysts Set Brixmor Property Group Inc  PT at $20.28
Analysts Set Brixmor Property Group Inc PT at $20.28
PIBBLE  One Day Trading Volume Tops $1,534.00
PIBBLE One Day Trading Volume Tops $1,534.00
Brokerages Set Teleflex Incorporated  Price Target at $386.11
Brokerages Set Teleflex Incorporated Price Target at $386.11
Opacity  Market Cap Reaches $2.08 Million
Opacity Market Cap Reaches $2.08 Million
MOAC Market Capitalization Tops $17.48 Million
MOAC Market Capitalization Tops $17.48 Million


© 2006-2019 Ticker Report